LD-2 disclosure · 1st Quarter - Report
VANDA PHARMACEUTICALS INC.
Income$40Kfee reported
Client
- Name
- VANDA PHARMACEUTICALS INC.
- Description
- Global biopharmaceutical company focused on innovative therapies.
- Location
- District of Columbia · United States of America
Registrant
- Description
- ​Consulting firm.
- Location
- Murfreesboro, Tennessee, United States of America
Lobbying activities
1 issuePharmacy
Issues affecting the pharmaceutical industry, including the prescription drug approval process, animal testing, and gastroparesis issues. Administration of the 21st Century Cares Act (Pub. L. No. 114-255). H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020. H.R. 6201, Families First Coronavirus Response Act. H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act. COVID-19 Clinical Trials. FY2021 Appropriations - outreach regarding appropriations language requests.
LobbyistsCICELY SIMPSON
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)